CATALOGO DEI PRODOTTI DELLA RICERCA

GAJOFATTO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.144
EU - Europa 4.838
AS - Asia 3.557
SA - Sud America 473
AF - Africa 127
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 10
Totale 15.178
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.067
CN - Cina 1.462
IT - Italia 1.252
SG - Singapore 1.215
GB - Regno Unito 1.166
SE - Svezia 431
BR - Brasile 423
RU - Federazione Russa 376
FR - Francia 375
HK - Hong Kong 363
DE - Germania 326
IE - Irlanda 302
FI - Finlandia 273
VN - Vietnam 101
KR - Corea 90
NL - Olanda 64
UA - Ucraina 61
EG - Egitto 60
IN - India 52
CA - Canada 44
TR - Turchia 44
BE - Belgio 43
JP - Giappone 38
ID - Indonesia 33
IR - Iran 32
AT - Austria 27
AU - Australia 26
PK - Pakistan 25
ES - Italia 20
PL - Polonia 20
CZ - Repubblica Ceca 19
CH - Svizzera 18
BD - Bangladesh 14
ZA - Sudafrica 14
MX - Messico 13
TG - Togo 12
CL - Cile 11
MK - Macedonia 11
AR - Argentina 10
EC - Ecuador 10
GR - Grecia 10
JO - Giordania 10
IL - Israele 9
MA - Marocco 9
IQ - Iraq 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
EU - Europa 7
UZ - Uzbekistan 7
DK - Danimarca 6
LV - Lettonia 6
NO - Norvegia 6
CO - Colombia 5
HU - Ungheria 5
KE - Kenya 5
OM - Oman 5
SD - Sudan 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
NP - Nepal 4
PA - Panama 4
PE - Perù 4
RO - Romania 4
TN - Tunisia 4
VE - Venezuela 4
CI - Costa d'Avorio 3
CY - Cipro 3
DZ - Algeria 3
LT - Lituania 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PT - Portogallo 3
PY - Paraguay 3
TH - Thailandia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
CR - Costa Rica 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AD - Andorra 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
GE - Georgia 1
HN - Honduras 1
IM - Isola di Man 1
KZ - Kazakistan 1
Totale 15.167
Salva come PNG Salva come JPEG
Città #
Dallas 1.056
Southend 987
Chandler 786
Singapore 555
Ashburn 513
Woodbridge 382
Ann Arbor 374
Hong Kong 355
Jacksonville 331
Dublin 303
Beijing 262
Verona 220
New York 157
Houston 148
Wilmington 126
Lawrence 122
Princeton 122
Jinan 109
Helsinki 105
Nanjing 103
Milan 89
Hebei 88
Shenyang 88
The Dalles 82
Munich 76
Los Angeles 72
Boardman 71
Columbus 61
Buffalo 58
Redondo Beach 58
Washington 57
Tianjin 45
Zhengzhou 45
Lancaster 44
Brussels 43
Council Bluffs 43
Dong Ket 43
Changsha 42
Redwood City 42
Ningbo 40
Rome 39
Hangzhou 38
Santa Clara 38
Haikou 37
Nanchang 37
Redmond 35
São Paulo 35
Jakarta 32
Turku 32
Taiyuan 30
Cairo 28
Guangzhou 28
Seattle 28
Sindelfingen 28
Taizhou 28
Tokyo 28
Bologna 27
Seoul 27
Fuzhou 21
Naples 21
Dearborn 20
Falls Church 20
Istanbul 20
Tehran 20
Amsterdam 19
Jiaxing 19
Norwalk 18
Nuremberg 18
Padova 18
Brooklyn 17
Catania 17
Boston 15
Olomouc 15
Shanghai 15
Atlanta 14
Belo Horizonte 14
Lanzhou 14
Warsaw 14
Clearwater 13
Frankfurt am Main 13
Moscow 13
San Francisco 13
Florence 12
Lappeenranta 12
Lomé 12
London 12
Montreal 12
Phoenix 12
Athens 11
Düsseldorf 11
Kent 11
Seongbuk-gu 11
Skopje 11
Amman 10
Auburn Hills 10
Brescia 10
Ho Chi Minh City 10
Melbourne 10
Plymouth 10
Riva 10
Totale 9.476
Salva come PNG Salva come JPEG
Nome #
Tolebrutinib. Bruton tyrosine kinase (BTK) inhibitor Treatment of multiple sclerosis 540
Psicologia positiva e disabilità: affrontare le sfide del futuro nell'adulto con disabilità acquisita, cronica e progressiva 404
The effectiveness of combining a home-based Digital motor Telerehabilitation program with conventional therapy in progressive multiple sclerosis: A study protocol for a multicenter, randomized controlled trial 241
Analisi delle alterazioni funzionali dell’arto superiore e dell’attività muscolare mediante emgs in pazienti con sclerosi multipla: uno studio “cross-sectional” 233
Gestione degli eventi avversi dei farmaci modificanti il decorso della malattia nella sclerosi multipla 226
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 202
Un caso di sclerosi multipla con esordio "tumor-like" e decorso benigno 197
A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome. 180
A bio-psycho-social co-created intervention for young adults with multiple sclerosis (ESPRIMO): rationale and study protocol for a feasibility study 180
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 175
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 162
A Case-control study of myelin oligodendrocyte glycoprotein and CD45 polymorphisms in multiple sclerosis in Verona, Italy 160
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 160
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study 157
GLI EFFETTI DI DUE DIVERSI TIPI DI TRATTAMENTO MOTORIO SULLE FUNZIONI COGNITIVE IN PAZIENTI CON SCLEROSI MULTIPLA 154
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 151
Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction 151
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 150
Risk factors for post-polio syndrome among an Italian population: a case-control study. 147
EFFETTI DI UN TRAINING DI INTEGRAZIONE SENSORI – MOTORIA SUI DISTURBI DELL’EQUILIBRIO IN PAZIENTI CON SCLEROSI MULTIPLA: UNO STUDIO RANDOMIZZATO CONTROLLATO 146
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 146
A case of multifocal CIS with unusual MRI features suggestive of Balo's concentric sclerosis 145
“If You Can’t Control the Wind, Adjust Your Sail”: Tips for Post-Pandemic Benefit Finding from Young Adults Living with Multiple Sclerosis. A Qualitative Study 145
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis 144
Intravenous immunoglobulin for post-polio syndrome: a randomized double-blind, placebo-controlled study 143
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 143
A case of acute fulminant multiple sclerosis treated with alemtuzumab 141
Cognitive onset in multiple sclerosis 140
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 138
Insights for fostering resilience in young adults with multiple sclerosis in the aftermath of the COVID-19 emergency: an Italian survey 136
An exploratory panel of cerebrospinal fluid biomarkers compared to standard diagnostic evaluation in initial demyelinating events suggestive of multiple sclerosis 132
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 130
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 130
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 128
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. 127
High-intensity robot-assisted hand training in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 126
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 125
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 123
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 122
Brentuximab vedotin: axonal microtubule's Apollyon 122
Amyloid myopathy: an intriguing diagnosis 121
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 120
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 120
Clinical and demographic predictors of response to first-line therapies in relapsing-remitting multiple sclerosis 119
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 119
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod 119
Epilepsy in multiple sclerosis: The role of temporal lobe damage 119
e-ESPRIMO: An e-health biopsychosocial intervention for young adults with Multiple sclerosis and medium/high disability. Co-creation phase 118
Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial 118
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? 118
The diagnosis of multiple sclerosis: pinpointing the concept of "no better explanation" 117
Acute cardiovascular dysfunction in multiple sclerosis: report of two cases and literature review 116
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 115
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 115
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 115
Effects of high-intensity robot-assisted training in hand function recovery and adl independence in individuals with multiple sclerosis: A randomized controlled single-blinded trial 114
Characterization of Upper Limb Impairments at Body Function, Activity, and Participation in Persons With Multiple Sclerosis by Behavioral and EMG Assessment: A Cross-Sectional Study 114
HCV-related nervous system disorders. 113
Response to Nagai et al. 113
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 111
EFFECTIVENESS OF A SENSORIMOTOR INTEGRATION TRAINING ON BALANCE DISORDERS IN PATIENTS WITH MULTIPLE SCLEROSIS: A RANDOMIZED CONTROLLED TRIAL 111
Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients 111
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis 110
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study. 107
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 107
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. 106
Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study 106
Increased cerebrospinal fluid cystatin C may predict disability after acute myelitis 104
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 104
Long survival and clinical stability in Marburg's variant multiple sclerosis. 103
Physicochemical properties of Aβ peptides in cerebrospinal fluid of Alzheimer’s disease patients 103
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 103
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 103
Two sisters with leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's syndrome? 102
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 102
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study) 101
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 101
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis 101
Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease. 99
Long lesions on initial spinal cord MRI predict a final diagnosis of acute disseminated encephalomyelitis versus multiple sclerosis in children 99
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 99
Evaluating upper upper limb dysfunctions in patients with multiple sclerosis: an electromyography cross sectional study 99
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 97
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 97
Effects of high-intensity robot-assisted hand training on upper limb recovery and muscle activity in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 96
Prognostic factors of acute partial transverse myelitis. 95
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 94
Early predictors of recovery, symptom recurrence, conversion to multiple sclerosis and long-term disability after acute myelitis 94
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 94
Prognostic indicators of “benign” clinical course in multiple sclerosis patients. 93
Study protocol on advance care planning in multiple sclerosis (ConCure-SM): intervention construction and multicentre feasibility trial 93
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 92
Assessing subjective quality of life domains after multiple sclerosis diagnosis disclosure 90
Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis. 89
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 87
Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibility 87
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. 85
Tumor-like multiple sclerosis: three cases misdiagnosed as primary brain neoplasm 85
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: an Italian multi-centre study 85
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy 84
Totale 13.054
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.773
article - articoli 52.504
book - libri 0
conference - conferenze 1.799
curatela - curatele 0
other - altro 384
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.086
Totale 111.546
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021725 0 0 0 116 137 103 28 41 65 35 104 96
2021/20221.177 98 418 31 123 27 23 11 74 36 32 74 230
2022/20232.274 153 291 212 372 175 483 30 142 246 30 88 52
2023/20241.867 65 114 181 157 241 402 92 154 20 107 178 156
2024/20253.312 169 200 201 486 174 148 188 178 478 246 274 570
2025/20262.326 680 484 1.092 70 0 0 0 0 0 0 0 0
Totale 15.399